MedTrace Logo

Tacrolimus for Malar Edema

NCT03715387 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-23

No results posted yet for this study

Summary

Elective lower eyelid surgery is a common cosmetic procedure. Facial swelling is a common complication. Studies suggest that this facial swelling is part of a complex inflammatory process. Topical tacrolimus has long been used to treat various inflammatory skin disorders. By combining our knowledge of facial swelling and tacrolimus mechanism of action, we can hypothesize that it can be used as a treatment to prevent this post-operative swelling. The purpose of this project is to apply topical tacrolimus to one of the patient's cheeks following facial surgery and compare the incidence of facial swelling to the opposite side control cheek.

Conditions

  • Edema Face

Interventions

DRUG

Tacrolimus Topical 0.1% Topical Ointment

Topical tacrolimus ointment

DRUG

Polysporin Ointment

Polysporin ointment

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Richard Warren, MD · University of British Columbia

  • Stahs Pripotnev, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03715387 on ClinicalTrials.gov